--2025/Q1-- / 1.000K--
--2024/Q4-- / 620.000--
Nov 12, 20242024/Q35.000K / 620.000--
Aug 8, 20242024/Q25.000K / 620.000--
May 9, 20242024/Q15.000K / 0.000--
US Stock MarketDetailed Quotes
ALT Altimmune
- 8.860
- +0.810+10.06%
Trading Nov 21 13:38 ET
630.16MMarket Cap-5643P/E (TTM)
9.055High7.910Low2.99MVolume8.050Open8.050Pre Close25.65MTurnover4.24%Turnover RatioLossP/E (Static)71.12MShares14.84052wk High4.73P/B625.49MFloat Cap2.76052wk Low--Dividend TTM70.60MShs Float978.000Historical High--Div YieldTTM14.22%Amplitude-1731.000Historical Low8.574Avg Price1Lot Size
Altimmune Key Stats
Altimmune Q3 2024 Earnings Date
Currency：USDNov 12, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 620.00 | 5.00K | +4.38K |
| Beat Est. | -99.83% | -98.62% | +706.45% |
| EPS | -0.36 | -0.32 | +0.04 |
| Beat Est. | +7.95% | +17.95% | +10.84% |
Analyst Rating
Nov 12, 2024
Altimmune Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Altimmune Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
